60-Day Notice

1117-0014 60-Day Notice.pdf

Application for Registration-DEA 224, Application of Registration Renewal-DEA 224A

60-Day Notice

OMB: 1117-0014

Document [pdf]
Download: pdf | pdf
Federal Register / Vol. 83, No. 240 / Friday, December 14, 2018 / Notices
If additional information is required,
please contact: Melody Braswell,
Department Clearance Officer, United
States Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE, Suite 3E.405B,
Washington, DC 20530.
Dated: December 10, 2018.
Melody Braswell,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2018–27058 Filed 12–13–18; 8:45 am]
BILLING CODE 4410–09–P

DEPARTMENT OF JUSTICE
[OMB Number 1117–0047]

Agency Information Collection
Activities; Proposed eCollection,
eComments Requested; Extension
Without Change of a Previously
Approved Collection; Application for
Import Quota for Ephedrine,
Pseudoephedrine, and
Phenylpropanolamine; DEA Form 488
Drug Enforcement
Administration, Department of Justice.
ACTION: 60-Day notice.
AGENCY:

The Department of Justice,
Drug Enforcement Administration
(DEA), will be submitting the following
information collection request to the
Office of Management and Budget for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 60 days until
February 12, 2019.
FOR FURTHER INFORMATION CONTACT: If
you have comments, especially on the
estimated public burden or associated
response time, suggestions, or need a
copy of the proposed information
collection instrument with instructions
or additional information, please
contact Kathy L. Federico, Diversion
Control Division, Drug Enforcement
Administration; Mailing Address: 8701
Morrissette Drive, Springfield, Virginia
22152; Telephone: (202) 598–6812.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;

amozie on DSK3GDR082PROD with NOTICES1

SUMMARY:

VerDate Sep<11>2014

16:57 Dec 13, 2018

Jkt 247001

—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information proposed to be collected
can be enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Overview of This Information
Collection
1. Type of Information Collection:
Extension of a currently approved
collection.
2. Title of the Form/Collection:
Application for Import Quota for
Ephedrine, Pseudoephedrine, and
Phenylpropanolamine.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
DEA Form 488. The applicable
component within the Department of
Justice is the Drug Enforcement
Administration, Diversion Control
Division.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract:
Affected public (Primary): Business or
other for-profit.
Affected public (Other): Not-for-profit
institutions; Federal, State, local, and
tribal governments.
Abstract: Pursuant to 21 U.S.C. 952
and 21 CFR 1315.34, any person who
desires to import the List I chemicals
Ephedrine, Pseudoephedrine, or
Phenylpropanolamine during the next
calendar year must apply on DEA Form
488 for an import quota for each such
List I chemical.
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: The DEA estimates 49
respondents complete 126 DEA Form
488 applications annually, and that each
form takes 0.5 hours to complete.
Respondents complete a separate DEA
Form 488 for each List I chemical for
which quota is sought.
6. An estimate of the total public
burden (in hours) associated with the
proposed collection: The DEA estimates
this collection takes a total of 63 annual
burden hours.
If additional information is required,
please contact: Melody Braswell,

PO 00000

Frm 00057

Fmt 4703

Sfmt 4703

64367

Department Clearance Officer, United
States Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE, Suite 3E.405B,
Washington, DC 20530.
Dated: December 10, 2018.
Melody Braswell,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2018–27061 Filed 12–13–18; 8:45 am]
BILLING CODE 4410–09–P

DEPARTMENT OF JUSTICE
[OMB Number 1117–0014]

Agency Information Collection
Activities; Proposed eCollection,
eComments Requested; Revision of a
Currently Approved Collection;
Application for Registration and
Applicaton for Registration Renewal;
DEA Forms 224, 224A
Drug Enforcement
Administration, Department of Justice.
ACTION: 60-Day notice.
AGENCY:

The Department of Justice
(DOJ), Drug Enforcement
Administration (DEA), will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 60 days until
February 12, 2019.
FOR FURTHER INFORMATION CONTACT:
If you have comments on the estimated
public burden or associated response
time, suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Kathy L. Federico, Diversion Control
Division, Drug Enforcement
Administration; Mailing Address: 8701
Morrissette Drive, Springfield, Virginia
22152; Telephone: (202) 598–6812.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
SUMMARY:

E:\FR\FM\14DEN1.SGM

14DEN1

64368

Federal Register / Vol. 83, No. 240 / Friday, December 14, 2018 / Notices

including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information proposed to be collected
can be enhanced; and
—Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
Overview of this information
collection:
1. Type of Information Collection:
Revision of a currently approved
collection.

2. Title of the Form/Collection:
Application for Registration and
Application for Registration Renewal.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
DEA Forms: 224, 224A. The applicable
component within the Department of
Justice is the Drug Enforcement
Administration, Diversion Control
Division.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract:
Affected public (Primary): Business or
other for-profit.
Affected public (Other): Not-for-profit
institutions; Federal, State, local, and
tribal governments.
Abstract: The Controlled Substances
Act (CSA) (21 U.S.C. 801–971) requires
Number of
annual
respondents *

DEA–224 (paper) ..........................................................
DEA–224 (electronic) ...................................................
DEA–224A (paper) .......................................................
DEA–224A (electronic) .................................................
Total .......................................................................

3,838
125,848
6,193
482,100
617,979

all persons that manufacture, distribute,
dispense, conduct research with,
import, or export any controlled
substance to obtain a registration issued
by the Attorney General. The DEA will
be revising the proposed information
collection instruments concerning the
liability questions on the Application
for Registration and Application for
Registration Renewal. Over the years,
many applicants have answered some of
the liability questions incorrectly. These
changes will avoid confusion to the
applicant by separating compound
questions into multiple parts that will
require the applicant to answer them
individually.
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond:

Average time per response **
0.22 hours (13 minutes) ...............................................
0.15 hours (9 minutes) .................................................
0.22 hours (13 minutes) ...............................................
0.08 hours (5 minutes) .................................................
.......................................................................................

Total annual
hours **
832
18,877
1,342
40,175
61,226

* Although practitioners are registered for a three-year cycle and the number of registrants is not equally distributed between years of the cycle,
October 1, 2017 to September 30, 2018 is a reasonable approximation of the average annual burden as it is very close to the average of the
three years. Additionally, the growth rate in the number of practitioners is low enough where the actual numbers for this period would not be materially different from the number expected for the next several years.
** An extra minute has been added to each average time per response to reflect the proposal for the first liability question in the application to
now be broken down into two parts.
*** Figures are rounded.

6. An estimate of the total public
burden (in hours) associated with the
proposed collection: The DEA estimates
that this collection takes 61,226 annual
burden hours.
If additional information is required
please contact: Melody Braswell,
Department Clearance Officer, United
States Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE, Suite 3E.405B,
Washington, DC 20530.
Dated: December 10, 2018.
Melody Braswell,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2018–27056 Filed 12–13–18; 8:45 am]

amozie on DSK3GDR082PROD with NOTICES1

BILLING CODE 4410–09–P

VerDate Sep<11>2014

16:57 Dec 13, 2018

Jkt 247001

[OMB Number 1117–0031]

Agency Information Collection
Activities; Proposed eCollection,
eComments Requested; Revision of a
Currently Approved Collection;
Application for Registration Under
Domestic Chemical Diversion Control
Act of 1993, Renewal Application for
Registration Under Domestic Chemical
Diversion Control Act of 1993; DEA
Forms 510, 510A
Drug Enforcement
Administration, Department of Justice.
ACTION: 60-day notice.
AGENCY:

The Department of Justice
(DOJ), Drug Enforcement
Administration (DEA), will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 60 days until
February 12, 2019.
SUMMARY:

PO 00000

Frm 00058

Fmt 4703

Sfmt 4703

If
you have comments on the estimated
public burden or associated response
time, suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Kathy L. Federico, Diversion Control
Division, Drug Enforcement
Administration; Mailing Address: 8701
Morrissette Drive, Springfield, Virginia
22152; Telephone: (202) 598–6812.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
FOR FURTHER INFORMATION CONTACT:

DEPARTMENT OF JUSTICE

E:\FR\FM\14DEN1.SGM

14DEN1


File Typeapplication/pdf
File Modified2019-02-15
File Created2019-02-15

© 2024 OMB.report | Privacy Policy